Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: A nonviral paradigm for coaxed differentiation

Eyayu Belay, Janka Mátrai, Abel Acosta-Sanchez, Ling Ma, Mattia Quattrocelli, L. Mátés, Pau Sancho-Bru, Martine Geraerts, Bing Yan, Joris Vermeesch, Melvin Yesid Rincón, Ermira Samara-Kuko, Zoltán Ivics, Catherine Verfaillie, Maurilio Sampaolesi, Zsuzsanna Izsvák, Thierry Vandendriessche, Marinee K L Chuah

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Adult stem cells and induced pluripotent stem cells (iPS) hold great promise for regenerative medicine. The development of robust nonviral approaches for stem cell gene transfer would facilitate functional studies and potential clinical applications. We have previously generated hyperactive transposases derived from Sleeping Beauty, using an in vitro molecular evolution and selection paradigm. We now demonstrate that these hyperactive transposases resulted in superior gene transfer efficiencies and expression in mesenchymal and muscle stem/progenitor cells, consistent with higher expression levels of therapeutically relevant proteins including coagulation factor IX. Their differentiation potential and karyotype was not affected. Moreover, stable transposition could also be achieved in iPS, which retained their ability to differentiate along neuronal, cardiac, and hepatic lineages without causing cytogenetic abnormalities. Most importantly, transposonmediated delivery of the myogenic PAX3 transcription factor into iPS coaxed their differentiation into MYOD+ myogenic progenitors and multinucleated myofibers, suggesting that PAX3 may serve as a myogenic "molecular switch" in iPS. Hence, this hyperactive transposon system represents an attractive nonviral gene transfer platform with broad implications for regenerative medicine, cell and gene therapy.

Original languageEnglish
Pages (from-to)1760-1771
Number of pages12
JournalStem Cells
Volume28
Issue number10
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Induced Pluripotent Stem Cells
Adult Stem Cells
Transposases
Regenerative Medicine
Stem Cells
Directed Molecular Evolution
Genes
Beauty
Factor IX
Aptitude
Cell- and Tissue-Based Therapy
Karyotype
Chromosome Aberrations
Genetic Therapy
Muscle Cells
Efficiency
Liver
Proteins

Keywords

  • iPS
  • Mesenchymal stem cell
  • Muscle
  • Myoblast
  • Sleeping beauty
  • Stem cell
  • Transposon

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Medicine

Cite this

Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells : A nonviral paradigm for coaxed differentiation. / Belay, Eyayu; Mátrai, Janka; Acosta-Sanchez, Abel; Ma, Ling; Quattrocelli, Mattia; Mátés, L.; Sancho-Bru, Pau; Geraerts, Martine; Yan, Bing; Vermeesch, Joris; Rincón, Melvin Yesid; Samara-Kuko, Ermira; Ivics, Zoltán; Verfaillie, Catherine; Sampaolesi, Maurilio; Izsvák, Zsuzsanna; Vandendriessche, Thierry; Chuah, Marinee K L.

In: Stem Cells, Vol. 28, No. 10, 10.2010, p. 1760-1771.

Research output: Contribution to journalArticle

Belay, E, Mátrai, J, Acosta-Sanchez, A, Ma, L, Quattrocelli, M, Mátés, L, Sancho-Bru, P, Geraerts, M, Yan, B, Vermeesch, J, Rincón, MY, Samara-Kuko, E, Ivics, Z, Verfaillie, C, Sampaolesi, M, Izsvák, Z, Vandendriessche, T & Chuah, MKL 2010, 'Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: A nonviral paradigm for coaxed differentiation', Stem Cells, vol. 28, no. 10, pp. 1760-1771. https://doi.org/10.1002/stem.501
Belay, Eyayu ; Mátrai, Janka ; Acosta-Sanchez, Abel ; Ma, Ling ; Quattrocelli, Mattia ; Mátés, L. ; Sancho-Bru, Pau ; Geraerts, Martine ; Yan, Bing ; Vermeesch, Joris ; Rincón, Melvin Yesid ; Samara-Kuko, Ermira ; Ivics, Zoltán ; Verfaillie, Catherine ; Sampaolesi, Maurilio ; Izsvák, Zsuzsanna ; Vandendriessche, Thierry ; Chuah, Marinee K L. / Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells : A nonviral paradigm for coaxed differentiation. In: Stem Cells. 2010 ; Vol. 28, No. 10. pp. 1760-1771.
@article{b8877bca16bc4375ac5ddbaa7f071774,
title = "Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: A nonviral paradigm for coaxed differentiation",
abstract = "Adult stem cells and induced pluripotent stem cells (iPS) hold great promise for regenerative medicine. The development of robust nonviral approaches for stem cell gene transfer would facilitate functional studies and potential clinical applications. We have previously generated hyperactive transposases derived from Sleeping Beauty, using an in vitro molecular evolution and selection paradigm. We now demonstrate that these hyperactive transposases resulted in superior gene transfer efficiencies and expression in mesenchymal and muscle stem/progenitor cells, consistent with higher expression levels of therapeutically relevant proteins including coagulation factor IX. Their differentiation potential and karyotype was not affected. Moreover, stable transposition could also be achieved in iPS, which retained their ability to differentiate along neuronal, cardiac, and hepatic lineages without causing cytogenetic abnormalities. Most importantly, transposonmediated delivery of the myogenic PAX3 transcription factor into iPS coaxed their differentiation into MYOD+ myogenic progenitors and multinucleated myofibers, suggesting that PAX3 may serve as a myogenic {"}molecular switch{"} in iPS. Hence, this hyperactive transposon system represents an attractive nonviral gene transfer platform with broad implications for regenerative medicine, cell and gene therapy.",
keywords = "iPS, Mesenchymal stem cell, Muscle, Myoblast, Sleeping beauty, Stem cell, Transposon",
author = "Eyayu Belay and Janka M{\'a}trai and Abel Acosta-Sanchez and Ling Ma and Mattia Quattrocelli and L. M{\'a}t{\'e}s and Pau Sancho-Bru and Martine Geraerts and Bing Yan and Joris Vermeesch and Rinc{\'o}n, {Melvin Yesid} and Ermira Samara-Kuko and Zolt{\'a}n Ivics and Catherine Verfaillie and Maurilio Sampaolesi and Zsuzsanna Izsv{\'a}k and Thierry Vandendriessche and Chuah, {Marinee K L}",
year = "2010",
month = "10",
doi = "10.1002/stem.501",
language = "English",
volume = "28",
pages = "1760--1771",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "10",

}

TY - JOUR

T1 - Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells

T2 - A nonviral paradigm for coaxed differentiation

AU - Belay, Eyayu

AU - Mátrai, Janka

AU - Acosta-Sanchez, Abel

AU - Ma, Ling

AU - Quattrocelli, Mattia

AU - Mátés, L.

AU - Sancho-Bru, Pau

AU - Geraerts, Martine

AU - Yan, Bing

AU - Vermeesch, Joris

AU - Rincón, Melvin Yesid

AU - Samara-Kuko, Ermira

AU - Ivics, Zoltán

AU - Verfaillie, Catherine

AU - Sampaolesi, Maurilio

AU - Izsvák, Zsuzsanna

AU - Vandendriessche, Thierry

AU - Chuah, Marinee K L

PY - 2010/10

Y1 - 2010/10

N2 - Adult stem cells and induced pluripotent stem cells (iPS) hold great promise for regenerative medicine. The development of robust nonviral approaches for stem cell gene transfer would facilitate functional studies and potential clinical applications. We have previously generated hyperactive transposases derived from Sleeping Beauty, using an in vitro molecular evolution and selection paradigm. We now demonstrate that these hyperactive transposases resulted in superior gene transfer efficiencies and expression in mesenchymal and muscle stem/progenitor cells, consistent with higher expression levels of therapeutically relevant proteins including coagulation factor IX. Their differentiation potential and karyotype was not affected. Moreover, stable transposition could also be achieved in iPS, which retained their ability to differentiate along neuronal, cardiac, and hepatic lineages without causing cytogenetic abnormalities. Most importantly, transposonmediated delivery of the myogenic PAX3 transcription factor into iPS coaxed their differentiation into MYOD+ myogenic progenitors and multinucleated myofibers, suggesting that PAX3 may serve as a myogenic "molecular switch" in iPS. Hence, this hyperactive transposon system represents an attractive nonviral gene transfer platform with broad implications for regenerative medicine, cell and gene therapy.

AB - Adult stem cells and induced pluripotent stem cells (iPS) hold great promise for regenerative medicine. The development of robust nonviral approaches for stem cell gene transfer would facilitate functional studies and potential clinical applications. We have previously generated hyperactive transposases derived from Sleeping Beauty, using an in vitro molecular evolution and selection paradigm. We now demonstrate that these hyperactive transposases resulted in superior gene transfer efficiencies and expression in mesenchymal and muscle stem/progenitor cells, consistent with higher expression levels of therapeutically relevant proteins including coagulation factor IX. Their differentiation potential and karyotype was not affected. Moreover, stable transposition could also be achieved in iPS, which retained their ability to differentiate along neuronal, cardiac, and hepatic lineages without causing cytogenetic abnormalities. Most importantly, transposonmediated delivery of the myogenic PAX3 transcription factor into iPS coaxed their differentiation into MYOD+ myogenic progenitors and multinucleated myofibers, suggesting that PAX3 may serve as a myogenic "molecular switch" in iPS. Hence, this hyperactive transposon system represents an attractive nonviral gene transfer platform with broad implications for regenerative medicine, cell and gene therapy.

KW - iPS

KW - Mesenchymal stem cell

KW - Muscle

KW - Myoblast

KW - Sleeping beauty

KW - Stem cell

KW - Transposon

UR - http://www.scopus.com/inward/record.url?scp=78149309453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149309453&partnerID=8YFLogxK

U2 - 10.1002/stem.501

DO - 10.1002/stem.501

M3 - Article

C2 - 20715185

AN - SCOPUS:78149309453

VL - 28

SP - 1760

EP - 1771

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 10

ER -